OptimizeRx Business Summary

OptimizeRx Corp (OPRX) operates a leading digital healthcare technology platform that facilitates real-time communication between life sciences companies, healthcare professionals (HCPs), and patients. The company generates revenue primarily through its intelligent technology platform, which is deeply integrated into electronic health record (EHR) and ePrescribing workflows. Its revenue model is increasingly shifting toward high-margin subscription fees via its Dynamic Audience Activation Platform (DAAP), complemented by transaction-based fees for digital interventions such as CopayCue™ and brand messaging. The business is organized into three primary segments: HCP Engagement, Patient Engagement (bolstered by the 2023 acquisition of Medicx Health), and Financial Messaging. OptimizeRx competes directly with point-of-care marketing firms such as ConnectiveRx, Aptus Health, Phreesia, and GoodRx, maintaining a specialized market position by providing exclusive, AI-driven access to clinical workflows that drive treatment adherence and brand awareness. Founded in 2006 by David A. Harrell, the company is currently led by Chief Executive Officer Steve Silvestro, who was appointed in March 2025 after serving as President and CCO. The executive team includes Ed Stelmakh as Chief Financial & Strategic Officer, Dr. Doug Besch as Chief Product & Technology Officer, and Sarah Bast, who joined as Chief Marketing Officer in July 2026 following a two-decade career at Publicis Health Media. The leadership team is supported by a high-pedigree Board of Directors chaired by Lynn O’Connor Vos and includes notable members such as Mary Varghese Presti (COO of Microsoft Health & Life Sciences), Gregory Wasson (former CEO of Walgreens Boots Alliance), and James Lang. This team focuses on a "Rule of 40" strategy, balancing sustained revenue growth with operational efficiency and AI-driven product innovation.